Form 4 Filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

This filing details a transaction by Mark J. Enyedy, a director at BIOMARIN PHARMACEUTICAL INC (BMRN). On June 2, 2026, Mr. Enyedy acquired 7,490 shares of Common Stock through a grant of restricted stock units. The transaction code is "A," indicating an acquisition. The reported price per share is $0.00, as noted in footnote F1, which clarifies that these were restricted stock units granted on the transaction date with no applicable price. Following this transaction, Mr. Enyedy now owns 21,040 shares of Common Stock directly.